About Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency
Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency is a rare disease catalogued by Orphanet (ORPHA:71212). It is associated with the HADH gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency trials.
Search ClinicalTrials.gov for "Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency" or filter by Orphanet code ORPHA:71212 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency. Updated daily.